Rate and Risk Factors of Reinfection, Recurrence, and Hospital Readmission Among SARS-Cov-2 Hospitalized Patients; a National Cohort Study

被引:2
|
作者
Taherpour, Niloufar [1 ,2 ]
Etemad, Koorosh [2 ]
Mokhayeri, Yaser [3 ]
Fallah, Saeid [4 ]
Ghorbani, Sahar Sotoodeh
Izadi, Neda [5 ]
Rahimi, Elham
Shahbazi, Fatemeh [6 ]
Seifi, Arash [7 ]
Mehri, Ahmad [2 ]
Feyzi, Rezvan [2 ]
Farhadi-Babadi, Kosar [2 ]
Nazari, Seyed Saeed Hashemi [1 ,2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Prevent Cardiovasc Dis Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Sch Publ Hlth & Safety, Dept Epidemiol, Tehran, Iran
[3] Lorestan Univ Med Sci, Shahid Rahimi Hosp, Cardiovasc Res Ctr, Khorramabad, Iran
[4] Golestan Univ Med Sci, Hlth Management & Social Dev Res Ctr, Gorgan, Iran
[5] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Res Ctr Social Determinants Hlth, Tehran, Iran
[6] Hamadan Univ Med Sci, Sch Hlth, Dept Epidemiol, Hamadan, Iran
[7] Univ Tehran Med Sci, Fac Med, Dept Infect Dis, Tehran, Iran
关键词
Reinfection; Recurrence; Patient Readmission; COVID-19; Pandemics; COVID-19; OUTBREAK; IRAN;
D O I
10.22037/aaem.v12i1.2327
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Reinfection and hospital readmission due to COVID-19 were significant and costly during the pandemic. This study aimed to assess the rate and risk factors of SARS-Cov-2 reinfection, recurrence, and hospital readmission, by analyzing the national data registry in Iran. Methods: This study was a retrospective cohort conducted from March 2020 to May 2021. A census method was used to consider all of the possible information in the national Medical Care Monitoring Center (MCMC) database obtained from the Ministry of Health and Medical Education; the data included information from all confirmed COVID-19 patients who were hospitalized and diagnosed using at least one positive Polymerase Chain Reaction (PCR) test by nasopharyngeal swab specimens. Univariate and multivariable Cox regression analyses were performed to assess the factors related to each studied outcome. Results: After analyzing data from 1,445,441 patients who had been hospitalized due to COVID-19 in Iran, the rates of overall reinfection, reinfection occurring at least 90 days after the initial infection, recurrence, and hospital readmission among hospitalized patients were 67.79, 26.8, 41.61, and 30.53 per 1000 person-years, respectively. Among all cases of hospitalized reinfection (48292 cases), 38.61% occurred more than 90 days from the initial SARS-Cov-2 infection. Getting infected with COVID-19 in the fifth wave of the disease compared to getting infected in the first wave (P<0.001), having cancer (P<0.001), chronic kidney disease (P<0.001), and age over 80 years (P<0.001) were respectively the most important risk factors for overall reinfection. In contrast, age 19-44 years (P<0.001), intubation (P<0.001), fever (P<0.001), and cough (P<0.001) in the initial admission were the most important protective factors of overall reinfection, respectively. Conclusions: Reinfection and recurrence of COVID-19 after recovery and the rate of hospital readmission after discharge were remarkable. Advanced or young age, as well as having underlying conditions like cancer and chronic kidney disease, increase the risk of infection and readmission.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Rate, risk factors, and clinical outcomes of SARS-CoV-2 reinfection vs. primary infection in readmitted COVID-19 patients in Iran: a retrospective cohort study
    Shahrbaf, Mohammadamin
    Alimohamadi, Yousef
    Arfaei, Reza Yousefi
    Salesi, Mahmood
    Izadi, Morteza
    Raei, Mehdi
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [22] High rate of reinfection with the SARS-CoV-2 Omicron variant
    Nhu Ngoc Nguyen
    Houhamdi, Linda
    Van Thuan Hoang
    Stoupan, Didier
    Fournier, Pierre-Edouard
    Raoult, Didier
    Colson, Philippe
    Gautret, Philippe
    JOURNAL OF INFECTION, 2022, 85 (02) : 206 - 208
  • [23] SARS-CoV-2 symptomatic reinfection among patients with primary antibody deficiency
    Marcus, Nufar
    Ashkenazi-Hoffnung, Liat
    Ovadia, Adi
    Dalal, Ilan
    Yoffe, Siril
    Kropach, Nesia
    Zuckerman, Neta
    Scheuerman, Oded
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1907 - 1909
  • [24] Incidence and risk factors related to SARS-CoV-2 infection, reinfection, seroconversion: Analysis of a healthcare workers cohort from a university hospital in Colombia
    Nieto, Maria A.
    Caballero, Nohemi
    Remolina, Camila I.
    Moreno, Sergio
    Vega, Daniela
    Quintero, Juliana
    IJID REGIONS, 2023, 9 : 63 - 71
  • [25] Nationwide study of rates of reinfection with SARS-CoV-2 among adults in Kuwait
    Al-Ahmad, Mona
    Alowayesh, Maryam
    Al Awadi, Abdullah
    Alghounaim, Mohammed
    Al Hashemi, Hashem
    Al Enezi, Laila
    Rawdhan, Hanouf
    Rodriguez-Bouza, Tito
    EASTERN MEDITERRANEAN HEALTH JOURNAL, 2023, 29 (02) : 146 - 150
  • [26] Risk factors for mortality among patients with SARS-CoV-2 infection: A longitudinal observational study
    Almaghlouth, Nouf K.
    Davis, Monique G.
    Davis, Michelle A.
    Anyiam, Felix E.
    Guevara, Roberto
    Antony, Suresh J.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) : 2021 - 2028
  • [27] SARS-CoV-2 Omicron infection in a cohort of hospitalized kidney transplant recipients: Risk factors of severity
    Cai, Zhitao
    Wang, Tianyu
    CLINICAL NEPHROLOGY, 2024, 101 (05) : 238 - 249
  • [28] AUTHOR'S REPLY TO SARS-COV-2 REINFECTION RATE IN VACCINATED HOSPITAL WORKERS: CORRESPONDENCE
    Ochoa-Hein, Eric
    Leal-Moran, Patricia E.
    Nava-Guzman, Karen A.
    Vargas-Fernandez, Abril T.
    Vargas-Fernandez, Jose F.
    Diaz-Rodriguez, Fabricio
    Armando Rayas-Bernal, Joel
    Gonzalez-Gonzalez, Ricardo
    Vazquez-Gonzalez, Pavel
    Huertas-Jimenez, Martha A.
    Rajme-Lopez, Sandra
    Ramos-Cervantes, Pilar
    Ibarra-Gonzalez, Violeta
    Garcia-Andrade, Luis A.
    Ledesma-Barrientos, Fernando
    Ponce-de-Leon, Alfredo
    Sifuentes-Osornio, Jose
    Galindo-Fraga, Arturo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2022, 74 (06): : 341 - 342
  • [29] Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study
    Albani, Filippo
    Sepe, Lilia
    Fusina, Federica
    Prezioso, Chiara
    Baronio, Manuela
    Caminiti, Federica
    Di Maio, Antonella
    Faggian, Barbara
    Franceschetti, Maria Elena
    Massari, Marco
    Salvaggio, Marcello
    Natalini, Giuseppe
    ECLINICALMEDICINE, 2020, 27
  • [30] Incidence and risk factors for early readmission after hospitalization for SARS-CoV-2 infection: results from a retrospective cohort study
    Cristina Kirkegaard
    Anna Falcó-Roget
    Adrián Sánchez-Montalvá
    Ángel Valls
    David Clofent
    Isabel Campos-Varela
    Sonia García-García
    Lina María Leguízamo
    Júlia Sellarès-Nadal
    Simeon Eremiev
    Miguel Villamarín
    Blanca Marzo
    Benito Almirante
    Òscar Len
    Infection, 2022, 50 : 371 - 380